Young D - Search Results

1

Absorption and disposition of colloidal drug delivery systems. I. High-performance liquid chromatographic (HPLC) analysis of a cyclosporin emulsion.

Corvari SJ, Hollenbeck RG, Leslie J, Plaisance KI, Young D. Corvari SJ, et al. Among authors: young d. Pharm Res. 1991 Jan;8(1):40-2. doi: 10.1023/a:1015870020952. Pharm Res. 1991. PMID: 2014206

2

Determination of clozapine and its major metabolites in human serum and rat plasma by liquid chromatography using solid-phase extraction and ultraviolet detection.

Fadiran EO, Leslie J, Fossler M, Young D. Fadiran EO, et al. Among authors: young d. J Pharm Biomed Anal. 1995 Feb;13(2):185-90. doi: 10.1016/0731-7085(93)e0020-n. J Pharm Biomed Anal. 1995. PMID: 7766727 No abstract available.

3

A reversed-phase ion-pair liquid chromatography method for the determination of 4-aminopyridine in Sprague-Dawley rats.

Fossler MJ, Leslie J, Burke M, Devane J, Young D. Fossler MJ, et al. Among authors: young d. J Pharm Biomed Anal. 1994 Feb;12(2):281-5. doi: 10.1016/0731-7085(94)90041-8. J Pharm Biomed Anal. 1994. PMID: 8003556 No abstract available.

4

Plasma pharmacokinetics and tissue distribution of paclitaxel in CD2F1 mice.

Eiseman JL, Eddington ND, Leslie J, MacAuley C, Sentz DL, Zuhowski M, Kujawa JM, Young D, Egorin MJ. Eiseman JL, et al. Among authors: young d. Cancer Chemother Pharmacol. 1994;34(6):465-71. doi: 10.1007/BF00685656. Cancer Chemother Pharmacol. 1994. PMID: 7923556

5

The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial.

Bever CT Jr, Young D, Anderson PA, Krumholz A, Conway K, Leslie J, Eddington N, Plaisance KI, Panitch HS, Dhib-Jalbut S, et al. Bever CT Jr, et al. Among authors: young d. Neurology. 1994 Jun;44(6):1054-9. doi: 10.1212/wnl.44.6.1054. Neurology. 1994. PMID: 8208399 Clinical Trial.

6

Sensitive electrochemical high-performance liquid chromatography assay for the simultaneous determination of haloperidol and reduced haloperidol.

Eddington ND, Young D. Eddington ND, et al. Among authors: young d. J Pharm Sci. 1988 Jun;77(6):541-3. doi: 10.1002/jps.2600770617. J Pharm Sci. 1988. PMID: 3171937

7

Estimation of the rate constants in a data-sparse environment: comparison of a mathematical method and least squares analysis.

Barcia EM, Newburger J, Young D. Barcia EM, et al. Among authors: young d. J Pharm Sci. 1988 Feb;77(2):175-7. doi: 10.1002/jps.2600770216. J Pharm Sci. 1988. PMID: 3361434

8

Biliary excretion of reduced haloperidol glucuronide.

Eddington ND, Young D. Eddington ND, et al. Among authors: young d. Psychopharmacology (Berl). 1990;100(1):46-8. doi: 10.1007/BF02245788. Psychopharmacology (Berl). 1990. PMID: 2296628

9

The impact of formulation and process changes on in vitro dissolution and the bioequivalence of piroxicam capsules.

Piscitelli DA, Bigora S, Propst C, Goskonda S, Schwartz P, Lesko LJ, Augsburger L, Young D. Piscitelli DA, et al. Among authors: young d. Pharm Dev Technol. 1998 Nov;3(4):443-52. doi: 10.3109/10837459809028625. Pharm Dev Technol. 1998. PMID: 9834946

10

Artificial neural networks applied to the in vitro-in vivo correlation of an extended-release formulation: initial trials and experience.

Dowell JA, Hussain A, Devane J, Young D. Dowell JA, et al. Among authors: young d. J Pharm Sci. 1999 Jan;88(1):154-60. doi: 10.1021/js970148p. J Pharm Sci. 1999. PMID: 9874718

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,428 results

Search Page

Filters